{"SLR NAME":"Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19
A Systematic Review and Meta-analysis","References":[{"title1":"Ramipril in High-Risk Patients With COVID-19","References":[{"title2":"Coronaviruses as the cause of respiratory infections","References":[{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"},{"title3":"Coronaviruses%20as%20the%20cause%20of%20respiratory%20infections"}]},{"title2":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003","References":[{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"},{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"},{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"},{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"},{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"},{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"},{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"},{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"},{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"},{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"},{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"},{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"},{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"},{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"},{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"},{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"},{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"},{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"},{"title3":"Epidemiology%20and%20cause%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20in%20Guangdong,%20People's%20Republic%20of%20China,%20in%20February,%202003"}]},{"title2":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","References":[]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"}]},{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","References":[]},{"title2":"Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"}]},{"title2":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","References":[]},{"title2":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","References":[{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"}]},{"title2":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis","References":[{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"},{"title3":"Tissue%20distribution%20of%20ACE2%20protein,%20the%20functional%20receptor%20for%20SARS%20coronavirus:%20a%20first%20step%20in%20understanding%20SARS%20pathogenesis"}]},{"title2":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","References":[]},{"title2":"Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers","References":[{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"}]},{"title2":"Angiotensin converting enzyme 2: a double-edged sword","References":[{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"},{"title3":"Angiotensin%20converting%20enzyme%202:%20a%20double-edged%20sword"}]},{"title2":"Coronavirus disease 2019 (COVID-19): do angiotensin-converting enzyme inhibitors/angiotensin receptor blockers have a biphasic effect?","References":[{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"},{"title3":"Coronavirus%20disease%202019%20(COVID-19):%20do%20angiotensin-converting%20enzyme%20inhibitors/angiotensin%20receptor%20blockers%20have%20a%20biphasic%20effect?"}]},{"title2":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","References":[{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"}]},{"title2":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","References":[{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension"},{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension"},{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension"},{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension"},{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension"},{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension"},{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension"},{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension"},{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension"},{"title3":"Renin-angiotensin%20system%20inhibitors%20improve%20the%20clinical%20outcomes%20of%20COVID-19%20patients%20with%20hypertension"}]},{"title2":"Renin-angiotensin system inhibition following transcatheter aortic valve replacement","References":[]},{"title2":"Impact of renin-angiotensin system inhibitors on clinical outcomes and ventricular remodelling after transcatheter aortic valve implantation: rationale and design of the RASTAVI randomised multicentre study","References":[{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"},{"title3":"Impact%20of%20renin-angiotensin%20system%20inhibitors%20on%20clinical%20outcomes%20and%20ventricular%20remodelling%20after%20transcatheter%20aortic%20valve%20implantation:%20rationale%20and%20design%20of%20the%20RASTAVI%20randomised%20multicentre%20study"}]},{"title2":"Coronavirus Disease 2019: Situation Report-76. April 5, 2020","References":[]},{"title2":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction","References":[]},{"title2":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","References":[{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"},{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"},{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"},{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"},{"title3":"Are%20patients%20with%20hypertension%20and%20diabetes%20mellitus%20at%20increased%20risk%20for%20COVID-19%20infection?"}]},{"title2":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?","References":[{"title3":"Can%20angiotensin%20receptor-blocking%20drugs%20perhaps%20be%20harmful%20in%20the%20COVID-19%20pandemic?"},{"title3":"Can%20angiotensin%20receptor-blocking%20drugs%20perhaps%20be%20harmful%20in%20the%20COVID-19%20pandemic?"},{"title3":"Can%20angiotensin%20receptor-blocking%20drugs%20perhaps%20be%20harmful%20in%20the%20COVID-19%20pandemic?"},{"title3":"Can%20angiotensin%20receptor-blocking%20drugs%20perhaps%20be%20harmful%20in%20the%20COVID-19%20pandemic?"},{"title3":"Can%20angiotensin%20receptor-blocking%20drugs%20perhaps%20be%20harmful%20in%20the%20COVID-19%20pandemic?"},{"title3":"Can%20angiotensin%20receptor-blocking%20drugs%20perhaps%20be%20harmful%20in%20the%20COVID-19%20pandemic?"},{"title3":"Can%20angiotensin%20receptor-blocking%20drugs%20perhaps%20be%20harmful%20in%20the%20COVID-19%20pandemic?"}]},{"title2":"Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19","References":[]},{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","References":[{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"}]},{"title2":"HFSA/ACC/AHA Statement Addressed Concerns Re: Using RAAS Antagonists in COVID-19","References":[]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","References":[]},{"title2":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019:COVID-NET, 14 states, March 1-30, 2020","References":[{"title3":"Hospitalization%20rates%20and%20characteristics%20of%20patients%20hospitalized%20with%20laboratory-confirmed%20coronavirus%20disease%202019:COVID-NET,%2014%20states,%20March%201-30,%202020"},{"title3":"Hospitalization%20rates%20and%20characteristics%20of%20patients%20hospitalized%20with%20laboratory-confirmed%20coronavirus%20disease%202019:COVID-NET,%2014%20states,%20March%201-30,%202020"},{"title3":"Hospitalization%20rates%20and%20characteristics%20of%20patients%20hospitalized%20with%20laboratory-confirmed%20coronavirus%20disease%202019:COVID-NET,%2014%20states,%20March%201-30,%202020"},{"title3":"Hospitalization%20rates%20and%20characteristics%20of%20patients%20hospitalized%20with%20laboratory-confirmed%20coronavirus%20disease%202019:COVID-NET,%2014%20states,%20March%201-30,%202020"}]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area","References":[]},{"title2":"Obesity and its implications for COVID-19 mortality","References":[{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"},{"title3":"Obesity%20and%20its%20implications%20for%20COVID-19%20mortality"}]},{"title2":"COVID-19 and endocrine diseases: a statement from the European Society of Endocrinology","References":[{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"},{"title3":"COVID-19%20and%20endocrine%20diseases:%20a%20statement%20from%20the%20European%20Society%20of%20Endocrinology"}]},{"title2":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?","References":[{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"}]},{"title2":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?","References":[{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"},{"title3":"COVID-19%20and%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20receptor%20blockers:%20what%20is%20the%20evidence?"}]}]},{"title1":"Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed With COVID-19","References":[{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"}]},{"title2":"An interactive web-based dashboard to track COVID-19 in real time","References":[{"title3":"An%20interactive%20web-based%20dashboard%20to%20track%20COVID-19%20in%20real%20time"},{"title3":"An%20interactive%20web-based%20dashboard%20to%20track%20COVID-19%20in%20real%20time"},{"title3":"An%20interactive%20web-based%20dashboard%20to%20track%20COVID-19%20in%20real%20time"}]},{"title2":"Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease","References":[{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"},{"title3":"Circulating%20angiotensin-converting%20enzyme%202%20activity%20in%20patients%20with%20chronic%20kidney%20disease%20without%20previous%20history%20of%20cardiovascular%20disease"}]},{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","References":[{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"}]},{"title2":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized With COVID-19","References":[]},{"title2":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China","References":[]},{"title2":"HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19. Available at:https://www.acc.org/latest-in-cardiology/articles/2020/03/17/08/59/hfsa-acc-aha-statement-addresses-concerns-re-using-raas-antagonists-in-covid-19. Accessed April 18, 2020.","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"}]},{"title2":"Effects of captopril related to increased levels of prostacyclin and angiotension-(1-7) in essential hypertension","References":[]},{"title2":"ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT study","References":[]},{"title2":"Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts","References":[{"title3":"Cell%20type-specific%20expression%20of%20the%20putative%20SARS-CoV-2%20receptor%20ACE2%20in%20human%20hearts"},{"title3":"Cell%20type-specific%20expression%20of%20the%20putative%20SARS-CoV-2%20receptor%20ACE2%20in%20human%20hearts"},{"title3":"Cell%20type-specific%20expression%20of%20the%20putative%20SARS-CoV-2%20receptor%20ACE2%20in%20human%20hearts"},{"title3":"Cell%20type-specific%20expression%20of%20the%20putative%20SARS-CoV-2%20receptor%20ACE2%20in%20human%20hearts"},{"title3":"Cell%20type-specific%20expression%20of%20the%20putative%20SARS-CoV-2%20receptor%20ACE2%20in%20human%20hearts"},{"title3":"Cell%20type-specific%20expression%20of%20the%20putative%20SARS-CoV-2%20receptor%20ACE2%20in%20human%20hearts"},{"title3":"Cell%20type-specific%20expression%20of%20the%20putative%20SARS-CoV-2%20receptor%20ACE2%20in%20human%20hearts"},{"title3":"Cell%20type-specific%20expression%20of%20the%20putative%20SARS-CoV-2%20receptor%20ACE2%20in%20human%20hearts"},{"title3":"Cell%20type-specific%20expression%20of%20the%20putative%20SARS-CoV-2%20receptor%20ACE2%20in%20human%20hearts"}]}]},{"title1":"Angiotensin?converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe <styled-content style="fixed-case" toggle="no">COVID?19</styled-content> infection in a multi?site <styled-content style="fixed-case" toggle="no">UK</styled-content> acute hospital trust","References":[{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"}]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy","References":[]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","References":[]},{"title2":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","References":[{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"},{"title3":"SARS-CoV-2%20cell%20entry%20depends%20on%20ACE2%20and%20TMPRSS2%20and%20is%20blocked%20by%20a%20clinically%20proven%20protease%20inhibitor"}]},{"title2":"Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors","References":[]},{"title2":"COVID-19 and the cardiovascular system","References":[{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"}]},{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","References":[{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"}]},{"title2":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?","References":[{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"},{"title3":"SARS-CoV2:%20should%20inhibitors%20of%20the%20renin-angiotensin%20system%20be%20withdrawn%20in%20patients%20with%20COVID-19?"}]},{"title2":"COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease","References":[{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"},{"title3":"COVID-19%20and%20heart%20failure:%20from%20infection%20to%20inflammation%20and%20angiotensin%20II%20stimulation.%20Searching%20for%20evidence%20from%20a%20new%20disease"}]},{"title2":"Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers","References":[{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"},{"title3":"Renin-angiotensin%20system%20blockers%20and%20the%20COVID-19%20pandemic:%20at%20present%20there%20is%20no%20evidence%20to%20abandon%20renin-angiotensin%20system%20blockers"}]},{"title2":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","References":[{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"},{"title3":"Angiotensin-converting%20enzyme%202%20protects%20from%20severe%20acute%20lung%20failure"}]},{"title2":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","References":[{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"}]},{"title2":"CogStack - experiences of deploying integrated information retrieval and extraction services in a large National Health Service Foundation Trust hospital","References":[{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"},{"title3":"CogStack%20-%20experiences%20of%20deploying%20integrated%20information%20retrieval%20and%20extraction%20services%20in%20a%20large%20National%20Health%20Service%20Foundation%20Trust%20hospital"}]},{"title2":"Semantic computational analysis of anticoagulation use in atrial fibrillation from real world data","References":[{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"},{"title3":"Semantic%20computational%20analysis%20of%20anticoagulation%20use%20in%20atrial%20fibrillation%20from%20real%20world%20data"}]},{"title2":"MedCAT - medical concept annotation tool","References":[]},{"title2":"MIMIC-III, a freely accessible critical care database","References":[{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"},{"title3":"MIMIC-III,%20a%20freely%20accessible%20critical%20care%20database"}]},{"title2":"Conducting sensitivity analysis for unmeasured confounding in observational studies using E-values: the evalue package","References":[]},{"title2":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China","References":[]},{"title2":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","References":[]},{"title2":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19","References":[{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"}]},{"title2":"Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study","References":[]},{"title2":"Should ethnicity serve as the basis for clinical trial design? Importance of race/ethnicity in clinical trials: lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","References":[]},{"title2":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19","References":[]},{"title2":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors","References":[{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"},{"title3":"Circulating%20plasma%20concentrations%20of%20angiotensin-converting%20enzyme%202%20in%20men%20and%20women%20with%20heart%20failure%20and%20effects%20of%20renin-angiotensin-aldosterone%20inhibitors"}]},{"title2":"Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers","References":[]}]},{"title1":"Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality","References":[{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","References":[{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"}]},{"title2":"COVID-19 and the cardiovascular system","References":[{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"}]},{"title2":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","References":[{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"}]},{"title2":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19","References":[{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20blockers%20and%20the%20risk%20of%20Covid-19"}]},{"title2":"Cardiovascular disease, drug therapy, and mortality in Covid-19","References":[]},{"title2":" https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang (13 May 2020).","References":[]}]},{"title1":"The characteristics and outcomes of 681 severe cases with COVID-19 in China","References":[{"title2":"A comprehensive literature review on the clinical presentation, and management of the Pandemic Coronavirus Disease 2019 (COVID-19)","References":[{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"},{"title3":"A%20comprehensive%20literature%20review%20on%20the%20clinical%20presentation,%20and%20management%20of%20the%20Pandemic%20Coronavirus%20Disease%202019%20(COVID-19)"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"}]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"}]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"}]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China","References":[]},{"title2":"Coronavirus disease 2019 (COVID-19): current status and future perspective","References":[]},{"title2":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"}]},{"title2":"Neutrophil-to-lymphocyte ratio: an emerging marker predicting prognosis in elderly adults with community-acquired pneumonia","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study","References":[]},{"title2":"A trial of Lopinavir-ritonavir in adults hospitalized with severe Covid-19","References":[{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"},{"title3":"A%20trial%20of%20Lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20Covid-19"}]},{"title2":"Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures","References":[]},{"title2":"Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-alpha","References":[]},{"title2":"COVID-19 and the cardiovascular system","References":[{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"},{"title3":"COVID-19%20and%20the%20cardiovascular%20system"}]},{"title2":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","References":[{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"},{"title3":"Prevalence%20of%20comorbidities%20and%20its%20effects%20in%20patients%20infected%20with%20SARS-CoV-2:%20a%20systematic%20review%20and%20meta-analysis"}]},{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","References":[{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"},{"title3":"Renin-angiotensin-aldosterone%20system%20inhibitors%20in%20patients%20with%20Covid-19"}]},{"title2":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","References":[]}]}]}